Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Shift work disrupts the body's natural clock, leading to health problems.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Stress can worsen skin diseases by affecting immune cells, hormones, and neurotransmitters in the skin.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Heavily hunted wolves have higher stress and reproductive hormone levels.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.